
STAAR Surgical (STAA) Stock Forecast & Price Target
STAAR Surgical (STAA) Analyst Ratings
Bulls say
Staar Surgical is a promising company with strong fundamentals, evidenced by its steady revenue and profit growth, geographic diversification, and potential for future growth in the US and China markets. The company's expansion efforts, positive feedback from ophthalmologists, and new product launch further support a positive outlook on the stock. While there may be some risks to consider, overall the company appears to be on a positive trajectory in the coming years.
Bears say
Staar Surgical is a company with strong top and bottom line results, indicating a significant increase in demand for its products. The company's record Q1 net sales, strong performance in the US and a much stronger-than-expected China recovery all suggest positive momentum for the company. The company's use of biocompatible Collamer material has also helped it to establish itself as a global leader in the industry. However, it should be noted that almost all of the revenue is generated from foreign sales, making the company heavily reliant on external markets and susceptible to external economic and political factors.
This aggregate rating is based on analysts' research of STAAR Surgical and is not a guaranteed prediction by Public.com or investment advice.
STAAR Surgical (STAA) Analyst Forecast & Price Prediction
Start investing in STAAR Surgical (STAA)
Order type
Buy in
Order amount
Est. shares
0 shares